Roussel E, Verbiest A, Milenkovic U, Van Cleynenbreugel B, Van Poppel H, Joniau S, et al. Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma. SJU [Internet]. 2020 Nov. 1 [cited 2024 Dec. 12];54(6):493-9. Available from: https://medicaljournalssweden.se/SJU/article/view/11750